| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/19/2008 | WO2008071679A1 Fibrin binding peptide conjugates for diagnostic and therapeutic applications. |
| 06/19/2008 | WO2008071639A1 Method for determining the oil quality |
| 06/19/2008 | WO2008071345A1 Rapid immune chromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071344A1 Antibody detection method involving oligonucleotide enhanced colloidal gold signal |
| 06/19/2008 | WO2008071343A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071342A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071341A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071340A1 Antigen detection method involving an oligonucleotide enhanced colloidal gold signal |
| 06/19/2008 | WO2008071339A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071336A1 Urinary immunochromatographic multiparameter detection cup |
| 06/19/2008 | WO2008071335A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071334A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071242A1 Method for inducing tumor apoptosis by increasing nitric oxide levels |
| 06/19/2008 | WO2008071201A1 Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfsl protein as a target for identifying effective compounds against pathological anxiety |
| 06/19/2008 | WO2008055080A3 Method for blocking non-specific protein binding on a functionalized surface |
| 06/19/2008 | WO2008054394A3 Method and apparatus for detection of toxic agents using photosynthetic organisms |
| 06/19/2008 | WO2008052299A3 Method for methylmalonic acid determination based on alkylative extraction associated to liquid chromatography coupled to mass spectrometry |
| 06/19/2008 | WO2008051900A3 High accuracy contamination estimation in hydrocarbon samples using gc x gc |
| 06/19/2008 | WO2008051804A3 Method and apparatus for providing a stable voltage to an analytical system |
| 06/19/2008 | WO2008051742A3 Transient decay amperometry |
| 06/19/2008 | WO2008050139A3 Laminin binding site |
| 06/19/2008 | WO2008047370A3 Compositions and methods for inducing angiogenesis |
| 06/19/2008 | WO2008046189A9 Proteins involved in after-cooking darkening in potatoes |
| 06/19/2008 | WO2008043952A3 System for determining the mass flow rate of nitrogen oxides emitted in the exhaust gases of an internal combustion engine |
| 06/19/2008 | WO2008043777B1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 06/19/2008 | WO2008039266A3 Stabilizing agents and capture ligands for use in assays measuring analyte concentrations |
| 06/19/2008 | WO2008036794B1 Assay preparation system |
| 06/19/2008 | WO2008036273A3 Receptor family profiling |
| 06/19/2008 | WO2008035204A3 Prediction and prophylactic treatment of type 1 diabetes |
| 06/19/2008 | WO2008034102A3 Surface mapping by optical manipulation of particles in relation to a functionalized surface |
| 06/19/2008 | WO2008032323A3 Method of determining lymph node metastasis |
| 06/19/2008 | WO2008028965A3 Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses thereof |
| 06/19/2008 | WO2008027942A3 Combination hepatitis c virus antigen and antibody detection method |
| 06/19/2008 | WO2008024399A3 Water quality monitoring device and method |
| 06/19/2008 | WO2008021179A3 System and method for transferring calibration data |
| 06/19/2008 | WO2007139815A3 Imaging and therapeutic method using progenitor cells |
| 06/19/2008 | WO2007135571A3 Blood group antigens of different types for diagnostic and therapeutic applications |
| 06/19/2008 | WO2007130534A3 Test for ovarian cancer by detecting abnormality in fancd2 pathway |
| 06/19/2008 | WO2007130523A3 Compositions and methods for detecting and treating hiv infection |
| 06/19/2008 | WO2007121465A3 Detection of proteins from circulating neoplastic cells |
| 06/19/2008 | WO2007121276A3 Enrichment of circulating fetal dna |
| 06/19/2008 | WO2007109321A3 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 06/19/2008 | WO2007103814A8 Angiogenesis pathway gene polymorphisms for therapy selection |
| 06/19/2008 | WO2007090124A3 Methodologies for the diagnosis and treatment of gastroesophageal reflux disease |
| 06/19/2008 | WO2007059779A3 Cyanine dyes and methods for detecting a target using said dyes |
| 06/19/2008 | WO2001034766A3 Protein monitoring the activity of small gtp-binding protein |
| 06/19/2008 | US20080148416 Animal models for monitoring activity of drug metabolizing enzymes; side effect reduction; assessing xenobiotics |
| 06/19/2008 | US20080147369 Methods, systems, and software for identifying functional biomolecules |
| 06/19/2008 | US20080146807 Indazole-carboxamide compounds as 5-HT4 receptor agonists |
| 06/19/2008 | US20080146786 Fluorescence resonance energy transfer (Fret) on substrates comprising syntaxin or mimetics thereof; for clostridium and tetanus toxins |
| 06/19/2008 | US20080146785 Antibody against tumor specific antigen as target |
| 06/19/2008 | US20080146784 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 06/19/2008 | US20080146781 Modified Human Four Helical Bundle Polypeptides and Their Uses |
| 06/19/2008 | US20080146675 Analyzing stability of atomoxetine hydrochloride by determining pH of sample of atomoxetine hydrochloride in aqueous solution; stable atomoxetine hydrochloride contains reduced amount of free hydrogen chloride, such that an aqueous solution has a pH of 4-7; shelf life, purity; attention-deficit disorder |
| 06/19/2008 | US20080146512 cell cycle control by administering opioid growth factor (OGF), which activates opioid growth factor receptor (OGFr) signaling. , the present invention provides a method for monitoring OGF modulation or treatment of a cell proliferation or growth related condition in a subject by assessing the kinase |
| 06/19/2008 | US20080146511 method of peptides, peptides, method and kit for the identification of infections by Mycobacterium leprae, as well as to pharmaceutical and immunological compositions containing as active principle(s), peptide(s) of Mycobacterium leprae or sequences functionally similar |
| 06/19/2008 | US20080146508 Soluble cyclic analogues of beta amyloid peptide |
| 06/19/2008 | US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor |
| 06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
| 06/19/2008 | US20080146505 47 Human Secreted Proteins |
| 06/19/2008 | US20080146502 method for modulating the sensation of satiety perception and to agents useful for same. Such agents are useful in modulating, controlling or otherwise affecting inter alia obesity, anorexia, weight maintenance, metabolic energy levels and/or inflammatory conditions in a subject |
| 06/19/2008 | US20080146498 Diagnostic Agent For Ischemic Heart Disease Risk Group |
| 06/19/2008 | US20080146495 methods for inhibiting the ability of HIV genes products to bind to the cytoplasmic domain of a CD4 receptor. This domain is necessary to the ability of the HIV Nef and Vpu gene products to connect the CD4 receptor to cellular degradation pathways. |
| 06/19/2008 | US20080146460 Optical probes and assays |
| 06/19/2008 | US20080146459 Protein Array and Process for Producing the Same |
| 06/19/2008 | US20080146456 Methods For Improving a Binding Characteristic of a Molecule |
| 06/19/2008 | US20080146453 Method For Identifying A Ligand Capable Of Selectively Modulating A Functional Cascade Involving A Target, And Uses Thereof For High-Throughput Screening Of Molecules Of Interest |
| 06/19/2008 | US20080145947 Using shift in spectral absorption of colorant, instigated via oxidation, as indicator of formaldehyde presence in urine |
| 06/19/2008 | US20080145946 Impurity of anastrozole intermediate, and uses thereof |
| 06/19/2008 | US20080145945 Includes a chromatographic medium that defines a detection zone that provides a signal (diazonium salt ) indicative of the presence or amount of bilirubin or urobilinogen; for testing a bodily fluid, such as urine, blood, mucous, saliva |
| 06/19/2008 | US20080145944 Have an aryl boronic acid residue having one or more electron withdrawing groups on the aromatic moiety, such that the molecule has enhanced oxidation resistance as compared to a corresponding molecule without the one or more electron withdrawing groups |
| 06/19/2008 | US20080145943 Cng2b: a novel human cyclic nucleotide-gated ion channel |
| 06/19/2008 | US20080145942 Metal detection reagents including an ammonium salt and methods of using the same |
| 06/19/2008 | US20080145941 Methods for Measuring the Metabolism of Neurally Dervied Biomolecules in Vivo |
| 06/19/2008 | US20080145938 Buffer solution for electroporation and a method comprising the use of the same |
| 06/19/2008 | US20080145932 Method and apparatus for cell recovery |
| 06/19/2008 | US20080145888 Assessment method |
| 06/19/2008 | US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 06/19/2008 | US20080145877 CA IX-Specific Inhibitors |
| 06/19/2008 | US20080145876 Poly(ethylene glycol) anti-body detection assays and kits for performing thereof |
| 06/19/2008 | US20080145875 Using immunoglobulin specific to extracellular matrix glycoprotein as evaluative tool in monitoring cell proliferative disorders |
| 06/19/2008 | US20080145874 Carbonic anhydrase (CA); enhance the efficacy of weak base chemotherapeutic drugs; positively charged sulfonamides that have membrane impermeability; diagnostic for cancer |
| 06/19/2008 | US20080145873 Identification of markers for disease including epitopes is effected in the presence of simulated redox state perturbations |
| 06/19/2008 | US20080145872 Expression of HLA proteins on non human cells |
| 06/19/2008 | US20080145871 Method for Determining an Allergic Response |
| 06/19/2008 | US20080145870 Marker for Neuromyelitis Optica |
| 06/19/2008 | US20080145869 Immunoassay method |
| 06/19/2008 | US20080145868 Method for diagnosing diabetes in a mammal |
| 06/19/2008 | US20080145867 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition |
| 06/19/2008 | US20080145866 Modified human thymic stromal lymphopoietin |
| 06/19/2008 | US20080145865 Assays for rab5 activity |
| 06/19/2008 | US20080145864 Using liver marker protlein as evaluative tool in detection and classification of hepatic disease |
| 06/19/2008 | US20080145863 Using affinity selection to measure concentration of preferential polypeptides in solution |
| 06/19/2008 | US20080145862 Molecular microarrays and helical peptides |
| 06/19/2008 | US20080145860 Encapsulated cell indicator system |
| 06/19/2008 | US20080145859 Diagnosis and treatment of cancer |
| 06/19/2008 | US20080145855 Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis |
| 06/19/2008 | US20080145850 Mass Labels |
| 06/19/2008 | US20080145843 Lateral flow assay device for detecting and determining presence of hydrolase and/or enzyme inhibitor in fluid |
| 06/19/2008 | US20080145840 Isothermal Titration Calorimetry Assays |